Explore 3 Stock Ideas & Industry Insights Download Free Report

Cognetivity Neurosciences Ltd

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
1000
Market Cap
0.01M

Momentum Score

…

Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cognetivity Neurosciences Ltd develops AI-driven cognitive assessment tools intended to detect early cognitive impairment and support dementia diagnosis. Its long-term growth drivers include the aging population and rising demand for scalable early-detection technologies, potential adoption by healthcare providers and clinical trials, and ongoing commercialization and regulatory progress that may support wider uptake.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.10M
Revenue Per Share
0.00
Gross Profit TTM
-1.27M
Debt / Equity
-
ROE
-642.83%
Net Debt
-
ROCE
82.30%
Diluted EPS TTM
-0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Income before tax -7.43M -13.13M -1.93M -2.66M -4.19M
Minority interest - - - - 0.00M
Net income -7.43M -13.13M -1.93M -2.65M -4.19M
Selling general administrative 5.61M 12.54M 2.38M 2.10M 3.48M
Gross profit - - - - -0.33M
Reconciled depreciation 0.02M 0.02M 0.01M 0.01M 0.00M
Ebit - -13.00M -2.40M -2.54M -4.09M
Ebitda -6.38M -13.04M -1.85M -2.60M -4.21M
Non operating income net other - - - - 0.00M
Operating income -6.39M -13.06M -2.46M -2.61M -4.21M
Other operating expenses - - - - 0.00M
Interest expense 1.03M 0.06M 0.06M 0.06M 0.00M
Tax provision 0.00M 0.00M 0.00M -0.02M -
Interest income - - - - 0.02M
Net interest income -1.03M -0.06M -0.06M -0.06M 0.02M
Extraordinary items - - - - 0.00M
Non recurring - - - - 0.00M
Other items - - - - 0.00M
Income tax expense - - 0.00M -0.02M 0.00M
Total revenue 0.05M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 6.44M 13.06M 2.46M 2.61M 4.21M
Cost of revenue - - - - 0.33M
Total other income expense net -0.02M -0.01M 0.59M 0.00M -0.00M
Discontinued operations - - - - 0.00M
Net income from continuing ops -7.43M -13.13M -1.93M -2.65M -4.19M
Net income applicable to common shares - -13.13M -1.93M -2.65M -4.19M
Preferred stock and other adjustments - - - - 0.00M
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Total assets 2.83M 2.00M 1.83M 0.75M 0.72M
Intangible assets 0.11M 0.09M 0.03M - 0.00M
Other current assets - - - - 0.00M
Total liab 12.72M 7.68M 0.96M 1.01M 0.24M
Total stockholder equity -9.89M -5.68M 0.86M -0.26M 0.48M
Deferred long term liab - - - - 0.00M
Other current liab 5.54M 0.15M 0.01M - 0.02M
Common stock - 12.88M 9.87M 7.03M 5.18M
Capital stock 15.67M 12.88M 9.87M 7.03M 5.18M
Retained earnings -31.40M -23.96M -10.84M -8.91M -6.26M
Other liab - 2.12M - - 0.00M
Good will - - - - 0.00M
Other assets - - - - 0.00M
Cash 2.24M 1.38M 1.36M 0.58M 0.25M
Total current liabilities 10.59M 5.56M 0.96M 1.01M 0.24M
Short term debt - - - - 0.00M
Short long term debt 1.29M 1.29M 0.31M 0.31M 0.00M
Other stockholder equity - 5.41M 1.83M 1.62M 1.56M
Property plant equipment - 0.06M 0.04M 0.04M 0.03M
Total current assets 2.66M 1.86M 1.75M 0.71M 0.69M
Long term investments - - - - 0.00M
Net tangible assets - -5.76M 0.83M -0.26M 0.48M
Short term investments - - - 0.00M 0.13M
Net receivables 0.14M 0.43M 0.08M 0.05M 0.20M
Long term debt - - - - 0.00M
Inventory - - - - 0.00M
Accounts payable 2.12M 0.99M 0.64M 0.63M 0.22M
Total permanent equity - - - - 0.00M
Noncontrolling interest in consolidated entity - - - - 0.00M
Temporary equity redeemable noncontrolling interests - - - - 0.00M
Accumulated other comprehensive income - - - - 0.00M
Additional paid in capital - - - - 0.00M
Common stock total equity - - - - 0.00M
Preferred stock total equity - - - - 0.00M
Retained earnings total equity - - - - 0.00M
Treasury stock - - - - 0.00M
Accumulated amortization - - - - 0.00M
Non currrent assets other - - - - 0.03M
Deferred long term asset charges - - - - 0.00M
Non current assets total 0.17M 0.15M 0.08M 0.04M 0.03M
Capital lease obligations - - - - 0.00M
Long term debt total - - - - 0.00M
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Investments -0.07M -0.10M -0.05M 0.13M 3.34M
Change to liabilities 0.00M 1.31M 0.14M 0.52M -0.11M
Total cashflows from investing activities - -0.10M -0.05M 0.11M 3.32M
Net borrowings - 1.27M 1.27M 0.33M 0.33M
Total cash from financing activities 6.88M 3.33M 2.79M 2.08M 0.30M
Change to operating activities -1.59M 4.78M -0.32M 0.23M -0.14M
Net income -7.43M -13.13M -1.93M -2.65M -4.19M
Change in cash 0.87M 0.02M 0.78M 0.33M 0.11M
Begin period cash flow 1.38M 1.36M 0.58M 0.25M 0.14M
End period cash flow 2.24M 1.38M 1.36M 0.58M 0.25M
Total cash from operating activities -5.94M -3.21M -1.96M -1.86M -3.49M
Issuance of capital stock 6.88M 1.27M 2.54M 1.63M -
Depreciation 0.02M 0.02M 0.01M 0.01M 0.00M
Other cashflows from investing activities - - - - 0.00M
Dividends paid - - - - 0.00M
Change to inventory - - - - 0.00M
Change to account receivables 0.06M -0.15M -0.15M -0.15M 0.00M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities - - 0.17M 0.17M 0.17M
Change to netincome - 3.94M 0.13M 0.03M 0.95M
Capital expenditures 0.07M 0.06M 0.02M 0.02M 0.02M
Change receivables - - - - 0.00M
Cash flows other operating - - - - 0.00M
Exchange rate changes - - - - 0.00M
Cash and cash equivalents changes - - - - 0.00M
Change in working capital 0.20M 5.95M -0.17M 0.75M -0.25M
Stock based compensation 0.56M 3.68M 0.08M 0.01M -
Other non cash items 0.94M 0.32M 0.08M 0.03M 0.08M
Free cash flow -6.01M -3.31M -2.01M -1.88M -3.51M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CGNSF
Cognetivity Neurosciences Ltd
-
-%
0.00 - 35.09 0.09 189.01 13.78 -2.05
VEEV
Veeva Systems Inc Class A
-0.05
0.02%
266.22 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-6.60
5.03%
124.50 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
-5.60
9.39%
54.01 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.07
1.31%
5.28 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Cognetivity Neurosciences Ltd

Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9

604 688 9588

Name Title Year Born
Dr. Sina Habibi Co-Founder, CEO & Director NA
Dr. Seyed-Mahdi Khaligh-Razavi Co-Founder & Chief Scientific Officer NA
Dr. Thomas Roger Sawyer M.B.A., Ph.D. COO, CFO, Company Sec. & Director 1970
Mr. Desmond M. Balakrishnan B.A., BA, L.L.B., LL.B. Legal Counsel & Director 1971
Dr. Christos Kalafatis Chief Medical Officer & Director NA
Mr. Jonathan El-Sharkawy Chief Technology Officer NA
Dr. Seyed-Mahdi Khaligh-Razavi Co-Founder & CIO NA
Dr. Thomas Roger Sawyer M.B.A., Ph.D. CFO, Company Secretary & Director 1970
Mr. Desmond M. Balakrishnan B.A., L.L.B. Legal Counsel & Director 1971

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…